Name: Consultations in Liver Disease,An Issue of Clinics in Liver Disease (Volume 24-3) (The Clinics: Internal Medicine, Volume 24-3) (en Inglés)
Price: 82150.00 CLP
Availability: InStock
Author: Flamm Steven L.
ISBN: 9780323710688

portada Consultations in Liver Disease,An Issue of Clinics in Liver Disease (Volume 24-3) (The Clinics: Internal Medicine, Volume 24-3) (en Inglés)

Formato

Libro Físico

Editorial

Elsevier

Autor

Flamm Steven L.

Idioma

Inglés

N° páginas

240

Encuadernación

Tapa Dura

ISBN13

9780323710688

Consultations in Liver Disease,An Issue of Clinics in Liver Disease (Volume 24-3) (The Clinics: Internal Medicine, Volume 24-3) (en Inglés)

Flamm Steven L. (Autor) · Elsevier · Tapa Dura

Libro Nuevo

$ 82.150

$ 164.300

Ahorras: $ 82.150

50% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Martes 11 de Junio y el Viernes 21 de Junio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Consultations in Liver Disease,An Issue of Clinics in Liver Disease (Volume 24-3) (The Clinics: Internal Medicine, Volume 24-3) (en Inglés)"

In collaboration with Consulting Editor, Dr. Norman Gitlin, Dr. Steven Flamm has put together another great update for the hepatology consult. Articles are submitted by expert author and in the format of the clinical review article, provide timely data for diagnosis and treatment. Specific areas addressed include the following: Management of esophageal and gastric varices; Severe thrombocytopenia in chronic liver disease and new management approaches; Pathology in chronic liver disease; Alpha 1 antitrypsin disease and chronic liver disease in adults; Evaluation of management of Budd-Chiari; HBV reactivation with immunosuppressive therapy; Homeopathic products and hepatotoxicity; New uses of TIPS; Dermatologic manifestations of chronic liver disease; Acute on chronic liver failure; Cholangiocarcinoma; Diagnosis and management of hepatic adenoma and focal nodular hyperplasia; Emerging data about the microbiome in chronic liver disease; and Acute viral hepatitis aside from HAV, HBV, and HCV. Readers will come away with the information they need to improve patient outcomes.